Prospective study of liver function following repeat halothane and enflurane.

Area of Science:

• Anesthesiology
• Hepatology
• Pharmacology

Background:

• Repeat anesthesia necessitates careful selection of anesthetic agents to minimize patient risk.
• Halogenated volatile anesthetics, such as halothane and enflurane, are commonly used.
• Understanding the comparative hepatotoxicity of these agents is crucial for patient safety.

Purpose of the Study:

• To compare the incidence of abnormal liver function tests following repeat administration of halothane versus enflurane.
• To identify risk factors associated with abnormal liver enzyme activity after repeat anesthesia.

Main Methods:

• A prospective study design was employed.
• Patients undergoing repeat anesthesia were allocated to receive either halothane or enflurane.
• Liver function was monitored through liver enzyme level assessments.

Main Results:

• Patients receiving repeat halothane anesthesia showed a higher frequency of abnormal liver enzyme results compared to those receiving repeat enflurane.
• Obesity and shorter intervals between anesthetic administrations were associated with increased likelihood of abnormal liver enzyme activity in the halothane group.

Conclusions:

• Enflurane appears to be a safer volatile agent for repeat anesthesia compared to halothane, regarding liver function.
• Clinical decisions regarding repeat anesthesia should consider the choice of volatile agent to mitigate hepatotoxic risks.